These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11066369)

  • 1. Reconstructing geneticization: a research manifesto.
    Hedgecoe AM
    Health Law J; 1999; 7():5-18. PubMed ID: 11066369
    [No Abstract]   [Full Text] [Related]  

  • 2. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene technology in research and commercialisation.
    Peacock J
    Australas Biotechnol; 1993; 3(5):278-81. PubMed ID: 7764290
    [No Abstract]   [Full Text] [Related]  

  • 4. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
    Paradise J
    Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
    [No Abstract]   [Full Text] [Related]  

  • 5. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
    Ardern-Jones A; Kenen R; Eeles R
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center.
    Shannon KM; Lubratovich ML; Finkelstein DM; Smith BL; Powell SN; Seiden MV
    Cancer; 2002 Jan; 94(2):305-13. PubMed ID: 11900216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and pathological characterization of inherited breast cancer.
    Borg A
    Semin Cancer Biol; 2001 Oct; 11(5):375-85. PubMed ID: 11562180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with an unclassified genetic variant in the BRCA1 or BRCA2 genes show different clinical features from those with a mutation.
    Gómez-García EB; Ambergen T; Blok MJ; van den Wijngaard A
    J Clin Oncol; 2005 Apr; 23(10):2185-90. PubMed ID: 15800311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
    Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
    Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of variations and haplotype analysis in the highly variable region of exon 11 of BRCA1 in Chinese women with sporadic breast cancer.
    Li Y; Zhang S; Xiao C; Su Z; Zhao Y; Chen W; Zhang G
    Hum Mutat; 2002 Nov; 20(5):404-5. PubMed ID: 12402341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
    Kewell B; Webster A
    Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
    [No Abstract]   [Full Text] [Related]  

  • 13. Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1.
    Judkins T; Hendrickson BC; Deffenbaugh AM; Scholl T
    Mutat Res; 2005 Jun; 573(1-2):168-79. PubMed ID: 15829246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
    Seo JH; Cho DY; Ahn SH; Yoon KS; Kang CS; Cho HM; Lee HS; Choe JJ; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Son GS; Lee JB; Koo BH
    Hum Mutat; 2004 Oct; 24(4):350. PubMed ID: 15365993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility?
    Schwartz MD; Tercyak KP; Peshkin BN; Valdimarsdottir H
    Nat Clin Pract Oncol; 2005 Jan; 2(1):24-5. PubMed ID: 16264852
    [No Abstract]   [Full Text] [Related]  

  • 17. Hope fear and genetics: judicial responses to biotechnology.
    Gold ER
    Judicature; 1999; 83(3):132-8. PubMed ID: 12737164
    [No Abstract]   [Full Text] [Related]  

  • 18. Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
    Kaufman DJ; Beaty TH; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1045-52. PubMed ID: 14578141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer research. Transatlantic war over BRCA1 patent.
    Balter M
    Science; 2001 Jun; 292(5523):1818. PubMed ID: 11397923
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between morphology, immunohistochemistry and molecular pathology in hereditary and sporadic breast cancer cases.
    Hadjisavvas A; Mikellidou C; Zenios A; Zouvani I; Adamou A; Christodoulou Ch; Kyriacou K
    Ultrastruct Pathol; 2002; 26(4):237-44. PubMed ID: 12227949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.